Recombinant viruses as a tool for therapeutic vaccination against human cancers.

Bonnet, M C; Tartaglia, J; Verdier, F; Kourilsky, P; Lindberg, A; Klein, M; Moingeon, P

Bonnet, M C; Tartaglia, J; Verdier, F; Kourilsky, P; Lindberg, A; Klein, M; Moingeon, P.

Affiliation

Bonnet MC; Aventis Pasteur, Campus Mérieux, 1541 Avenue Marcel Mérieux, 69280, Marcy l'Etoile, France.

Immunol Lett ; 74(1): 11-25, 2000 Sep 15.

Article in En | MEDLINE | ID: mdl-10996623

Subject(s)

Cancer Vaccines/therapeutic use; DNA, Viral/genetics; Genetic Vectors/genetics; Immunotherapy, Active; Neoplasms/therapy; Vaccines, Synthetic/therapeutic use; Antigens, Neoplasm/genetics; Antigens, Neoplasm/immunology; Cancer Vaccines/adverse effects; Cancer Vaccines/genetics; Cancer Vaccines/immunology; Clinical Trials as Topic; DNA, Viral/therapeutic use; Genetic Vectors/adverse effects; Genetic Vectors/therapeutic use; Humans; Immune Tolerance/immunology; Neoplasms/genetics; Neoplasms/immunology; Vaccines, Synthetic/adverse effects; Vaccines, Synthetic/genetics; Vaccines, Synthetic/immunology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: DNA, Viral / Vaccines, Synthetic / Immunotherapy, Active / Cancer Vaccines / Genetic Vectors / Neoplasms Type of study: Guideline / Prognostic_studies Limits: Humans Language: En Journal: Immunol Lett Year: 2000 Document type: Article Affiliation country: France Country of publication: Netherlands

Search on Google

Add to My VHL

XML

PubMed Links